User:Mr. Ibrahem/Imiglucerase

Imiglucerase, sold under the brand name Cerezyme, is a medication used to treat Gaucher's disease. Specifically it is used for type I and III disease. It is given by injection into a vein. It is used long term.

Common side effects include shortness of breath, cough, headache, itchiness, and rash. Other side effects may include pulmonary hypertension, pneumonia, and allergic reactions. It is a form of the enzyme β-glucocerebrosidase produced by recombinant DNA technology.

Imiglucerase was approved for medical use in the United States in 1994 and Europe in 1997. In the United Kingdom 400 units costs the NHS about £1,100 as of 2021. In the United States this amount costs about 1,650 USD.